Covid-19 situation ‘stable’ in Switzerland despite rise in cases
The Federal Office of Public Health (FOPH) has reported more than 400 new daily coronavirus cases for the first time since mid-April. Despite the 405 cases registered in Switzerland and Liechtenstein on Friday, the office’s head of communicable diseases says he is not worried.
This content was published on
1 minute
Keystone-SDA/ts
Español
es
COVID-19: Situación ‘estable’ en Suiza pese al aumento de casos
The reproduction rate is just under 1, meaning there is no exponential growth, Stefan Kuster told the media in Bern on Friday. The situation is also stable in terms of hospitalisations and deaths, he said. “At the moment we’re not talking of a second wave; we’re talking of a slow increase in infections. The efforts of the population and the cantons are bearing fruit.”
Kuster said it is impossible to predict how the situation will develop. “That depends on people returning from abroad, on the effect of the resumption of major events, and on autumn, which could have an influence. Everyone is called upon to prevent a strong resurgence [of cases],” he said.
On Wednesday the government announced a series of conditions for the resumption of mass events in Switzerland, which have been limited since March to curb the spread of coronavirus infections.
More
More
Strict anti-Covid measures applied to Swiss mass events
This content was published on
The government has announced a series of conditions for the resumption of mass events in Switzerland to curb the spread of coronavirus infections.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.